Molecular mechanism of manganese exposure-induced dopaminergic toxicity

Brain Research Bulletin

Volumn 76, Issue 4, 2008, Pages 361-367

  Prabhakaran, K ^a   Ghosh, D ^b   Chapman, G D ^a   Gunasekar, P G ^a  

^a AIR FORCE RESEARCH LABORATORY   (United States)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Apoptosis; Dopamine; Manganese; Neurotoxicity; Oxidative stress; Transcription factor

Indexed keywords

7 NITROINDAZOLE; ALPHA TOCOPHEROL; DOPAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; MANGANESE; REACTIVE OXYGEN METABOLITE; SN 50;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; CELL DEATH; CELL INTERACTION; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ACTIVATION; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELLS, CULTURED; DOPAMINE; ENZYME ACTIVATION; MANGANESE; MANGANESE POISONING; MESENCEPHALON; NERVE DEGENERATION; NEURONS; NEUROTOXINS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 43849113143     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.03.004     Document Type: Article

References (53)

1. Alam A.I., Jenner A., Daniel S.E., Lees A.J., Cairns N., Marsden C.D., Jenner P., and Halliwell B. Oxidative DNA damage in the Parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69 (1997) 1196-1203
2. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357 (2001) 593-615
3. Aschner M. Manganese: brain transport and emerging research needs. Environ. Health Perspect. 108 (2000) 429-432
4. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38 (1995) 357-366
5. Brewer G.J., Torricelli J.R., Evege E.K., and Price P.J. Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35 (1993) 567-576
6. Brouillet E.T., Shinova I., McGarvey U., Hochberg F., and Beal M.F. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp. Neurol. 120 (1993) 89-94
7. Chen J., Wersinger C., and Sidhu A. Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric oxide synthase activation and cytotoxicity. J. Biol. Chem. 278 (2003) 28089-28100
8. Chun H.S., Gibson G.E., DeGiorgio L.A., Zhang H., Kidd V.J., and Son J.H. Dopaminergic cell death induced by MPP (+), oxidant and specific neurotoxicants shares the common molecular mechanism. J. Neurochem. 76 (2001) 1010-1021
9. Dehmer T., Lindenau J., Haid S., Dichgans J., and Schulz J.B. Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J. Neurochem. 74 (2000) 2213-2216
10. Dehmer T., Heneka M.T., Sastre M., Dichgans J., and Schulz J.B. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IKBα induction and block of NF-κB and iNOS activation. J. Neurochem. 88 (2004) 494-501
11. Desole M.S., Esposito G., Migheli R., Sircana S., Delogu M.R., Fresu L., Miele M., De Natale G., and Miele E. Glutathione deficiency potentiates manganese toxicity in rat striatum and brain stem and PC12 cells. Pharmacol. Res. 36 (1997) 285-292
12. Douglas C.J., Prabhakaran K., Li L., Gunasekar P.G., Shou Y., Borowitz J.L., and Isom G.E. Cyanide enhancement of dopamine-induced apoptosis in mesencephalon cells involves mitochondrial dysfunction and oxidative stress. Neurotoxicology 24 (2003) 333-342
13. Dunnett S., and Bjorklund A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399 (1999) A32-A39
14. Erikson K.M., Thompson K., Aschner J., and Aschner M. Manganese neurotoxxicity: a focus on the neonate. Pharmacol. Ther. 113 (2007) 369-377
15. Florence T.M., and Stauber J.L. Manganese catalysis of dopamine oxidation. Sci. Total Environ. 78 (1989) 233-240
16. Gavin C.E., Gunter K.K., and Gunter T.E. Manganese and calcium transport in mitochondria: implication for manganese toxicity. Neurotoxicology 20 (1999) 445-454
17. Ghosh S., and Karim M. Missing pieces in the NF-κB puzzle. Cell 109 (2002) 881-896
18. Gorlach C., Hortobagyi T., Hortobagyi S., and Benyo Z. Neuronal nitric oxide synthase inhibitor has a neuroprotective effect in a rat model of brain injury. Restor. Neurol. Neurosci. 17 (2000) 71-76
19. Gunasekar P.G., Kanthasamy A.G., Borowitz J.L., and Isom G.E. Monitoring intracellular nitric oxide formation by dichlorofluorescein in neuronal cells. J. Neurosci. Methods 61 (1995) 15-21
20. Gunasekar P.G., Li L., Prabhakaran K., Ebyl V., Borowitz J.L., and Isom G.E. Mechanisms of the apoptotic and necrotic actions of trimethyltin in cerebellar granule cells. Toxicol. Sci. 64 (2001) 83-89
21. Gunasekar P.G., Prabhakaran K., and Ghosh D. Dopamine modulation enhances manganese toxicity involving oxidative stress and inducible nitric oxide synthase: a key mechanism for cell death [abstract]. Soc. Neurosci. 42 (2003) 91
22. Hastings T.G., Lewis D.A., and Zigmond M.J. Role of oxidative stress in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 1056-1061
23. He Y., Imam S.Z., Dong Z., Jankovic J., Ali S.F., Appel S.H., and Le W. Role of nitric oxide in rotenone-induced nigrostrial injury. J. Neurochem. 86 (2003) 1338-1345
24. Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.P., Ruberg M., Faucheux B.A., Agid Y., and Hirsch E.C. Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 7531-7536
25. Iregren A. Using psychological tests for the early detection of neurotoxic effects of low level manganese exposure. Neurotoxicology 15 (1994) 671-677
26. Iregren A. Manganese neurotoxicity in industrial exposures: proof of effects, critical exposure level, and sensitive tests. Neurotoxicology 20 (1999) 315-323
27. Jenner P. Oxidative damage in neurodegenerative disease. Lancet 344 (1994) 796-798
28. Kaiser J. Manganese: a high-octane disputes. Science 300 (2003) 926-928
29. Keinanen R., Vartianen N., and Koistinaho J. Molecular cloning and characterization of rat inducible nitric oxide synthase (iNOS) gene. Gene (Amst.) 234 (1999) 297-305
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
31. Lau Y.S., Petroske E., Meredith G.E., and Wang J.Q. Elevated neuronal nitric oxide synthase expression in chronic haloperidol-treated rats. Neuropharmacology 45 (2003) 986-994
32. Lee J. Manganese intoxication. Arch. Neurol. 57 (2000) 597-599
33. Liberatore G.T., Jackson-Lewis V., Vukosavic S., Mandir A.S., Vila M., McAuliffe W.G., Dawson V.L., Dawson T.M., and Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegenerationin the MPTP model of Parkinson disease. Nat. Med. 5 (1999) 1403-1409
34. Liccione J.J., and Maines M.D. Selective vulnerability of glutathione metabolism and cellular defense mechanism in rat striatum to Mn. J. Pharmacol. Exp. Ther. 247 (1988) 156-161
35. Linert W., Herlinger E., Jameson R.F., Kienzl E., Jellinger K., and Youdim M.B.H. Dopamine, 6-hydroxydopamine, iron and dioxygen-their mutual interactions and possible implications in the development of Parkinson's disease. Biochim. Biophys. Acta 1316 (1996) 160-168
36. Migheli R., Godani C., Sciola L., Delogu M.R., Serra P.A., Zangani D., Natale G.D., Miele E., and Desole M.S. Enhancing effect of manganese on L-DOPA-induced apoptosis in PC 12 cells: role of oxidative stress. J. Neurochem. 73 (1999) 1155-1163
37. Nakao N., Nakai K., and Itakura T. Metabolic inhibition enhances selective toxicity of L-DOPA towards mesencephalic dopamine neurons in vitro. Brain Res. 777 (1997) 202-209
38. Nomura Y. NF-κB activation and IκBα dynamism involved in iNOS and chemokine induction in astroglial cells. Life Sci. 68 (2001) 1695-1701
39. Ogawa N., Edamastu R., Mizukawa K., Asanura M., Kohno M., and Mosi A. Degeneration of dopaminergic neurons and free radicals. Possible participation of levodopa. Adv. Neurol. 60 (1993) 242-256
40. Pal K.P., Samii A., and Calne D.B. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology 20 (1999) 227-238
41. Parenti M., Rusconi L., Cappabianca V., Parati E., and Gropetti A. Role of dopamine in manganese toxicity. Brain Res. 473 (1988) 236-240
42. Rabinovich A.D., and Hastings T.G. Role of endogenous glutathione in the oxidation of dopamine. J. Neurochem. 71 (1998) 2071-2078
43. Rahman I., and MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax 53 (1998) 601-612
44. Ramesh G.T., Ghosh D., and Gunasekar P.G. Early activation of transcription factor, NF-κB following low-level Manganese exposure. Toxcol. Lett. 136 (2002) 151-158
45. Shen X.M., and Dryhurst G. Iron and manganese-catalyzed autoxidation of dopamine in the presence of l-cysteine: possible insights into iron and manganese-mediated dopaminergic neurotoxicity. Chem. Res. Toxicol. 11 (1998) 824-837
46. Snyder R.D., and Friedman M.B. Enhancement of cytotoxicity and clastogenicity of L-DOPA and dopamine by manganese and copper. Mutat. Res. 405 (1998) 1-8
47. Sun A.Y., Yang W.L., and Kim H.D. Free radical and lipid peroxidation in manganese-induced neuronal injury. Ann. NY Acad. Sci. 679 (1993) 358-363
48. USCENTCOM Enhanced Particulate Matter Surveillance Sampling Protocol, U.S. Army Center for Health Promotion and Preventive Medicine (USACHPPM), through October 1, 2006.
49. Vassault S.A. Lactate dehydrogenase. In: Bergemeyer H. (Ed). Methods of Enzyme Analysis vol. 13 (1983), Verlag Chemie, Weinheim 118-133
50. Wink D.A., and Mitchell J.B. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 25 (1998) 434-456
51. Xia Q.W., Cho H., Kashiwabara Y., Baum M., Weidner J.R., Elliston K., Mumford R., and Nathan C. Carboxyl terminus of inducible nitric oxide synthase. Contribution to NADPH binding and enzymatic activity. J. Biol. Chem. 269 (1994) 28500-28505
52. Zeevalk G.D., Derr-Yellin E., and Nicklas W.J. Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockers. J. Pharmacol. Exp. Ther. 275 (1995) 1124-1130
53. Zigmond M.J., Hastings T.G., and Abercromie E.D. Neurochemical response to 6-hydroxy-dopamine and L-DOPA therapy: implications in Parkinson's disease. Ann. NY Acad. Sci. 648 (1992) 71-86